New stroke combo could save more brain cells

NCT ID NCT07137832

First seen Jan 02, 2026 · Last updated Apr 28, 2026 · Updated 15 times

Summary

This study tests whether adding a clot-dissolving drug directly into the brain's arteries during standard clot removal helps people recover better after a medium-sized stroke. About 530 adults with acute ischemic stroke will be randomly assigned to get the drug plus standard care or standard care alone. The main goal is to see if more people are independent (able to care for themselves) 90 days later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.